CLASS III Drug recall · Reported 29 Apr 2015 · FDA Enforcement Report

Rose Bengal GloStrips (rose bengal) Ophthalmic Strips recalled by Nomax

Nomax is recalling Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually, distributed nationwide in the US. The recall was initiated on 24 Mar 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 8925, Exp 07/17; 8972, Exp 10/17; and 9195, Exp 04/18
NDC51801-004
UPC351801004408
Quantity recalled5,514 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0962-2015
FDA event ID
70552
Recalling firm
Nomax, Saint Louis, MO
Manufacturer
Nomax Inc.
Classification
Class III
Status
Terminated
Recall initiated
24 Mar 2015
FDA classified
21 Apr 2015
Reported
29 Apr 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay
Drug class
Eye Drops

Timeline

24 Mar 2015Recall initiated by company
21 Apr 2015Classified by FDA+28 days
29 Apr 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of rose bengal present in the strips.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped strip (NDC 51801-004-01), barcode (01)00351801004019, packaged in 100-count strips per carton (NDC 51801-004-40, UPC 3 51801 00440 8), Nomax, Inc., St. Louis, MO 63123 USA.

Where it was distributed

Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobago, and St. Lucia

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of rose bengal present in the strips.

Which lots are affected?

Lot #: 8925, Exp 07/17; 8972, Exp 10/17; and 9195, Exp 04/18

Where was it sold?

Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobago, and St. Lucia

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 70552

More recalls from Nomax

All 8